Tobacco smoking in treatment-resistant schizophrenia patients is associated with impaired cognitive functioning, more severe negative symptoms, and poorer social adjustment

References

• MorisanoDBacherIAudrain-McGovernJGeorgeTPMechanisms underlying the comorbidity of tobacco use in mental health and addictive disordersCan J Psychiatry200954635636719527556
   PubMed Web of Science ®Google Scholar
• KeefeRSHarveyPDCognitive impairment in schizophreniaHandb Exp Pharmacol2012213113723027411
   PubMedGoogle Scholar
• WintererGWhy do patients with schizophrenia smoke?Curr Opin Psychiatry201023211211920051860
   PubMed Web of Science ®Google Scholar
• KumariVPostmaPNicotine use in schizophrenia: the self medication hypothesesNeurosci Biobehav Rev20052961021103415964073
   PubMed Web of Science ®Google Scholar
• WingVCWassCESohDWGeorgeTPA review of neurobiological vulnerability factors and treatment implications for comorbid tobacco dependence in schizophreniaAnn N Y Acad Sci201212488910622129082
   PubMed Web of Science ®Google Scholar
• SesackSRGraceAACortico-Basal Ganglia reward network: microcircuitryNeuropsychopharmacology2010351274719675534
   PubMed Web of Science ®Google Scholar
• LivingstonePDSrinivasanJKewJNalpha7 and non-alpha7 nicotinic acetylcholine receptors modulate dopamine release in vitro and in vivo in the rat prefrontal cortexEur J Neurosci200929353955019187266
   PubMed Web of Science ®Google Scholar
• GeorgeTPVerricoCDPicciottoMRRothRHNicotinic modulation of mesoprefrontal dopamine neurons: pharmacologic and neuroanatomic characterizationJ Pharmacol Exp Ther20002951586610991961
   PubMed Web of Science ®Google Scholar
• FreedmanRAdamsCELeonardSThe alpha7-nicotinic acetylcholine receptor and the pathology of hippocampal interneurons in schizophreniaJ Chem Neuroanat2000203–429930611207427
   PubMed Web of Science ®Google Scholar
• LeonardSGaultJHopkinsJAssociation of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophreniaArch Gen Psychiatry200259121085109612470124
   PubMed Web of Science ®Google Scholar
• HarrisJGKongsSAllensworthDEffects of nicotine on cognitive deficits in schizophreniaNeuropsychopharmacology20042971378138515138435
   PubMed Web of Science ®Google Scholar
• SmithRCWarner-CohenJMatuteMEffects of nicotine nasal spray on cognitive function in schizophreniaNeuropsychopharmacology200631363764316160711
   PubMed Web of Science ®Google Scholar
• DuludeLLabelleAKnottVJAcute nicotine alteration of sensory memory impairment in smokers with schizophreniaJ Clin Psychopharmacol201030554154820814324
   PubMed Web of Science ®Google Scholar
• KnottVShahDMillarANicotine, Auditory Sensory Memory, and sustained attention in a human ketamine model of Schizophrenia: moderating influence of a hallucinatory traitFront Pharmacol2012317223060793
   PubMed Web of Science ®Google Scholar
• WingVCBacherISaccoKAGeorgeTPNeuropsychological performance in patients with schizophrenia and controls as a function of cigarette smoking statusPsychiatry Res2011188332032621669462
   PubMed Web of Science ®Google Scholar
• SaccoKATermineASeyalAEffects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanismsArch Gen Psychiatry200562664965915939842
   PubMed Web of Science ®Google Scholar
• ZhangXYChenDCXiuMHCigarette smoking, psychopathology and cognitive function in first-episode drug-naive patients with schizophrenia: a case-control studyPsychol Med Epub11132012
   Web of Science ®Google Scholar
• KrishnadasRJauharSTelferSShivashankarSMcCreadieRGNicotine dependence and illness severity in schizophreniaBr J Psychiatry2012201430631222878134
   PubMed Web of Science ®Google Scholar
• LehmanAFLiebermanJADixonLBPractice guideline for the treatment of patients with schizophrenia, second editionAm J Psychiatry2004161Suppl 215615000267
   PubMed Web of Science ®Google Scholar
• DemjahaAMurrayRMMcGuirePKKapurSHowesODDopamine synthesis capacity in patients with treatment-resistant schizophreniaAm J Psychiatry2012169111203121023034655
   PubMed Web of Science ®Google Scholar
• ZhangXYChen daCXiuMHCigarette smoking and cognitive function in Chinese male schizophrenia: a case-control studyPLoS One201275e3656322570726
   PubMed Web of Science ®Google Scholar
• ZhangXYLiangJChen daCCigarette smoking in male patients with chronic schizophrenia in a Chinese population: prevalence and relationship to clinical phenotypesPLoS One201272e3093722347412
   PubMed Web of Science ®Google Scholar
• FerketichAKFossatiRApoloneGAn evaluation of the Italian version of the Fagerstrom Test for Nicotine DependencePsychol Rep2008102368769418763437
   PubMed Web of Science ®Google Scholar
• PancheriPBrugnoliRCarilliLDelle ChiaieRMarconiPLPetrucciRMValutazione dimensionale della sintomatologia schizofrenica. Validazione della versione italiana della Scala per la valutazione dei Sintomi Positivi e Negativi (PANSS)Giornale Italiana Psicopatologia199516075
   Google Scholar
• MorosiniPLMaglianoLBrambillaLUgoliniSPioliRDevelopment, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioningActa Psychiatr Scand2000101432332910782554
   PubMed Web of Science ®Google Scholar
• AnselmettiSPolettiSErmoliEThe Brief Assessment of Cognition in Schizophrenia. Normative data for the Italian populationNeurol Sci2008292859218483705
   PubMed Web of Science ®Google Scholar
• KeefeRSGoldbergTEHarveyPDGoldJMPoeMPCoughenourLThe Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive batterySchizophr Res2004682–328329715099610
   PubMed Web of Science ®Google Scholar
• BarchDMCeaserACognition in schizophrenia: core psychological and neural mechanismsTrends Cogn Sci2012161273422169777
   PubMed Web of Science ®Google Scholar
• LaruelleMKegelesLSAbi-DarghamAGlutamate, dopamine, and schizophrenia: from pathophysiology to treatmentAnn N Y Acad Sci2003100313815814684442
   PubMed Web of Science ®Google Scholar
• MoleroPOrtunoFZalacainMPatino-GarciaAClinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatmentPharmacogenomics J20077641842617363961
   PubMed Web of Science ®Google Scholar
• GuptaMBhatnagarPGroverSAssociation studies of catechol-O-methyltransferase (COMT) gene with schizophrenia and response to antipsychotic treatmentPharmacogenomics200910338539719290789
   PubMed Web of Science ®Google Scholar
• ChenJLipskaBKHalimNFunctional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brainAm J Hum Genet200475580782115457404
   PubMed Web of Science ®Google Scholar
• PerreaultMLO’DowdBFGeorgeSRDopamine receptor homooligomers and heterooligomers in schizophreniaCNS Neurosci Ther2011171525721199449
   PubMed Web of Science ®Google Scholar
• KantrowitzJTJavittDCThinking glutamatergically: changing concepts of schizophrenia based upon changing neurochemical modelsClin Schizophr Relat Psychoses20104318920020880830
   PubMedGoogle Scholar
• GoffDCCoyleJTThe emerging role of glutamate in the pathophysiology and treatment of schizophreniaAm J Psychiatry200115891367137711532718
   PubMed Web of Science ®Google Scholar
• de BartolomeisASarappaCMagaraSIasevoliFTargeting glutamate system for novel antipsychotic approaches: relevance for residual psychotic symptoms and treatment resistant schizophreniaEur J Pharmacol20126821–311122387855
   PubMed Web of Science ®Google Scholar
• OkuboYSuharaTSuzukiKDecreased prefrontal dopamine D1 receptors in schizophrenia revealed by PETNature199738566176346369024661
   PubMed Web of Science ®Google Scholar
• Abi-DarghamAXuXThompsonJLIncreased prefrontal cortical D(1) receptors in drug naive patients with schizophrenia: a PET study with [(1)(1)C]NNC112J Psychopharmacol201226679480521768159
   PubMed Web of Science ®Google Scholar
• BlandJMAltmanDGMultiple significance tests: the Bonferroni methodBMJ199531069731707833759
   PubMed Web of Science ®Google Scholar
• PernegerTVWhat’s wrong with Bonferroni adjustmentsBMJ19983167139123612389553006
   PubMed Web of Science ®Google Scholar